Fragile X syndrome screening: Difference between revisions
No edit summary |
|||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}} | ||
{{Fragile X syndrome}} | {{Fragile X syndrome}} | ||
==Overview== | ==Overview== | ||
Routine [[screening]] for Fragile X syndrome is not recommended. [[Prenatal]] or preconceptional [[screening]] is only recommended among high risk individuals such as [[Family History|family]] members with history of [[mental retardation]], [[movement disorders]] or [[Fragile X syndrome|Fragile X syndrome.]] | |||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for Fragile X syndrome. | There is insufficient evidence to recommend routine screening for [[Fragile X syndrome]]. The gold standard test to look for [[Trinucleotide repeat disorder|CGG]] expansion is [[Polymerase chain reaction]] (PCR) followed by [[Southern blot]] test to refine expanded size and [[methylation]] status. For prenatal screening, samples are obtained from [[Chorionic villus sampling|chorionic villus]] samples (CVS) at 11-13 weeks or [[Amniocyte|amniocytes]] by [[amniocentesis]] at >15 weeks period of [[gestation]]. | ||
== References == | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 15:31, 24 November 2021
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
|
Fragile X syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fragile X syndrome screening On the Web |
|
American Roentgen Ray Society Images of Fragile X syndrome screening |
|
Risk calculators and risk factors for Fragile X syndrome screening |
Overview
Routine screening for Fragile X syndrome is not recommended. Prenatal or preconceptional screening is only recommended among high risk individuals such as family members with history of mental retardation, movement disorders or Fragile X syndrome.
Screening
There is insufficient evidence to recommend routine screening for Fragile X syndrome. The gold standard test to look for CGG expansion is Polymerase chain reaction (PCR) followed by Southern blot test to refine expanded size and methylation status. For prenatal screening, samples are obtained from chorionic villus samples (CVS) at 11-13 weeks or amniocytes by amniocentesis at >15 weeks period of gestation.